Florida Hospital Waterman Cancer Institute recently announced it has a new tool proven to protect prostate cancer patients from the side effects of radiation therapy. A press release offered these statistics from the American Cancer Society and the National Cancer Institute:
- Prostate cancer is second only to skin cancer as most frequently diagnosed in men.
- Worldwide, prostate cancer growth is expected to reach 1.7 million new cases by 2030.
Recently, FHW injected a patient for the first time with SpaceOAR hydrogel, the first FDA-cleared spacing device to protect the rectum during radiation therapy for prostate cancer.
This system temporarily positions the anterior rectal wall away from the prostate during radiotherapy, thus creating the space to protect the rectum. Florida Hospital Waterman Cancer Institute is the first cancer center in Lake County to offer this advance technology.
“The SpaceOAR hydrogel placement is tolerated well, and we have level 1 clinical evidence to show that it decreases side effects and improves quality of life after radiation therapy to the prostate. We are excited to offer SpaceOAR and extend this benefit to our prostate cancer patients,” says Dr. Anudh Jain, radiation oncologist at Florida Hospital Waterman Cancer Institute.